Monitoring suicide risk in adolescents using biometric data
Proximal Risk for Suicide in Adolescents
Oregon Health and Science University · NCT06400810
This study is testing whether using data from wearable devices can help spot rising suicide risk in teenagers so that they can get help before a crisis happens.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 144 (estimated) |
| Ages | 13 Years to 17 Years |
| Sex | All |
| Sponsor | Oregon Health and Science University (other) |
| Locations | 1 site (Portland, Oregon) |
| Trial ID | NCT06400810 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the use of biometric data from wearable technology to monitor and identify escalating suicidal symptoms in adolescents. By focusing on physiologic parameters, the study seeks to develop a personalized predictive tool that can enhance outpatient identification of at-risk youth before a crisis necessitates emergency intervention. The approach includes evaluating heart rate variability and employing machine learning to analyze temporal relationships in biometric signals related to suicidality. The ultimate goal is to improve early intervention strategies for adolescents presenting with acute suicidality.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 13-17 who present to the emergency department or inpatient psychiatric unit with acute suicidality or a suicide attempt.
Not a fit: Patients who are acutely agitated, not medically cleared from a suicide attempt, or have significant developmental delays may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective early identification and intervention strategies for adolescents at risk of suicide.
How similar studies have performed: While the use of biometric data for monitoring mental health is an emerging field, this specific approach to suicide risk assessment in adolescents is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * subjects aged 13-17 years * presenting to the ED or inpatient psychiatric unit with a chief complaint of acute suicidality or attempt. Exclusion Criteria: * acutely agitated patients per the treating physician * adolescents who are not medically cleared from a suicide attempt * no legally authorized representative available to provide consent * parental report of significant developmental delay or autism diagnosis * prisoners * non-English speaking.
Where this trial is running
Portland, Oregon
- OHSU — Portland, Oregon, United States (RECRUITING)
Study contacts
- Principal investigator: David Sheridan, MD — Oregon Health and Science University
- Study coordinator: David Sheridan, MD
- Email: sheridda@ohsu.edu
- Phone: 503-494-1691
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Suicide, Mental Health Issue, adolescent, emergency